IBDEI3BK ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1563,0)
 ;;=SAME DAY ADM/DISCHARGE^12^121
 ;;^UTILITY(U,$J,358.4,1564,0)
 ;;=INPT CONSULTATIONS^5^121
 ;;^UTILITY(U,$J,358.4,1565,0)
 ;;=INITIAL HOSPITAL CARE^6^121
 ;;^UTILITY(U,$J,358.4,1566,0)
 ;;=SUBSEQUENT HOSPITAL CARE^7^121
 ;;^UTILITY(U,$J,358.4,1567,0)
 ;;=HOSPITAL CARE D/C SERVICES^8^121
 ;;^UTILITY(U,$J,358.4,1568,0)
 ;;=SUBSEQUENT OBSERVATION CARE^10^121
 ;;^UTILITY(U,$J,358.4,1569,0)
 ;;=OBSERVATION CARE D/C SERVICES^11^121
 ;;^UTILITY(U,$J,358.4,1570,0)
 ;;=PROLONGED SERVICES^5^122
 ;;^UTILITY(U,$J,358.4,1571,0)
 ;;=VENOUS^7^122
 ;;^UTILITY(U,$J,358.4,1572,0)
 ;;=BP MONITORING^1^122
 ;;^UTILITY(U,$J,358.4,1573,0)
 ;;=MEDICATION^4^122
 ;;^UTILITY(U,$J,358.4,1574,0)
 ;;=CARDIOVASCULAR^2^122
 ;;^UTILITY(U,$J,358.4,1575,0)
 ;;=CATHETER^3^122
 ;;^UTILITY(U,$J,358.4,1576,0)
 ;;=TEAM CONFERENCE^6^122
 ;;^UTILITY(U,$J,358.4,1577,0)
 ;;=HEMODIALYSIS-ESRD^14^123
 ;;^UTILITY(U,$J,358.4,1578,0)
 ;;=PERITONEAL DIALYSIS ENCOUNTER^23^123
 ;;^UTILITY(U,$J,358.4,1579,0)
 ;;=CARDIOLOGY/CARDIORENAL SYNDROME^2^123
 ;;^UTILITY(U,$J,358.4,1580,0)
 ;;=COMPLICATIONS/OTHER^4^123
 ;;^UTILITY(U,$J,358.4,1581,0)
 ;;=CYSTIC KIDNEY DISEASE^5^123
 ;;^UTILITY(U,$J,358.4,1582,0)
 ;;=DIABETES/DIABETIC RENAL DISEASE^6^123
 ;;^UTILITY(U,$J,358.4,1583,0)
 ;;=FLUID/ELECTROLYTE DISORDER^8^123
 ;;^UTILITY(U,$J,358.4,1584,0)
 ;;=GENERAL SYMPTOMS^9^123
 ;;^UTILITY(U,$J,358.4,1585,0)
 ;;=GENITAL/URINARY^10^123
 ;;^UTILITY(U,$J,358.4,1586,0)
 ;;=HEMATOLOGY^12^123
 ;;^UTILITY(U,$J,358.4,1587,0)
 ;;=HYPERTENSION^15^123
 ;;^UTILITY(U,$J,358.4,1588,0)
 ;;=INFECTIOUS DISEASE^16^123
 ;;^UTILITY(U,$J,358.4,1589,0)
 ;;=NEPHRITIS GLUMERULONEPHRITIS^18^123
 ;;^UTILITY(U,$J,358.4,1590,0)
 ;;=NEPHRITIS INTERSTITIAL^19^123
 ;;^UTILITY(U,$J,358.4,1591,0)
 ;;=NEPHROTIC SYNDROME^21^123
 ;;^UTILITY(U,$J,358.4,1592,0)
 ;;=OBSTRUCTIVE UROPATHY^22^123
 ;;^UTILITY(U,$J,358.4,1593,0)
 ;;=TRANSPLANT^26^123
 ;;^UTILITY(U,$J,358.4,1594,0)
 ;;=CKD/KIDNEY DISEASE^3^123
 ;;^UTILITY(U,$J,358.4,1595,0)
 ;;=HEMODIALYSIS-AKI^13^123
 ;;^UTILITY(U,$J,358.4,1596,0)
 ;;=ACUTE KIDNEY INJURY^1^123
 ;;^UTILITY(U,$J,358.4,1597,0)
 ;;=GLOMERULAR DISEASE^11^123
 ;;^UTILITY(U,$J,358.4,1598,0)
 ;;=KIDNEY INVOLVMNT IN SYSTEMIC DISEASE^17^123
 ;;^UTILITY(U,$J,358.4,1599,0)
 ;;=NEPHROLITHASIS^20^123
 ;;^UTILITY(U,$J,358.4,1600,0)
 ;;=POISONING & INTOXICATIONS^24^123
 ;;^UTILITY(U,$J,358.4,1601,0)
 ;;=DIALYSIS^7^123
 ;;^UTILITY(U,$J,358.4,1602,0)
 ;;=SUICIDE IDEATIONS/ATTEMPTS^25^123
 ;;^UTILITY(U,$J,358.4,1603,0)
 ;;=OB/GYN PROCEDURES^1^124
 ;;^UTILITY(U,$J,358.4,1604,0)
 ;;=INJECTABLES/IMMUNIZATIONS^5^124
 ;;^UTILITY(U,$J,358.4,1605,0)
 ;;=INJECTION/IMMUNIZATION ADMIN^4^124
 ;;^UTILITY(U,$J,358.4,1606,0)
 ;;=FOREIGN BODY^3^124
 ;;^UTILITY(U,$J,358.4,1607,0)
 ;;=UA/FINGERSTICK^13^124
 ;;^UTILITY(U,$J,358.4,1608,0)
 ;;=FLUSHES^2^124
 ;;^UTILITY(U,$J,358.4,1609,0)
 ;;=OTHER PROCEDURES^7^124
 ;;^UTILITY(U,$J,358.4,1610,0)
 ;;=MATERNAL CARE^6^124
 ;;^UTILITY(U,$J,358.4,1611,0)
 ;;=PREVENTIVE COUNSELING^8^124
 ;;^UTILITY(U,$J,358.4,1612,0)
 ;;=PREVENTIVE-ESTAB PT^9^124
 ;;^UTILITY(U,$J,358.4,1613,0)
 ;;=PREVENTIVE-NEW PT^10^124
 ;;^UTILITY(U,$J,358.4,1614,0)
 ;;=SUPPLIES^12^124
 ;;^UTILITY(U,$J,358.4,1615,0)
 ;;=PROLONG SERVICES^11^124
 ;;^UTILITY(U,$J,358.4,1616,0)
 ;;=NEW PATIENT^2^125
 ;;^UTILITY(U,$J,358.4,1617,0)
 ;;=ESTABLISHED PATIENT^1^125
 ;;^UTILITY(U,$J,358.4,1618,0)
 ;;=CONSULTATIONS^3^125
